EU Clears Danaher $21B GE Biopharma Buy With Divestitures
Danaher has won the go-ahead from the European Commission to buy General Electrics' biopharma portfolio for $21.4 billion on the condition that Danaher first unloads five biotech companies that manufacture key...To view the full article, register now.
Already a subscriber? Click here to view full article